Amyloid β-based therapy for Alzheimer's disease: Challenges, successes and future
Y Zhang, H Chen, R Li, K Sterling… - Signal transduction and …, 2023 - nature.com
Amyloid β protein (Aβ) is the main component of neuritic plaques in Alzheimer's disease
(AD), and its accumulation has been considered as the molecular driver of Alzheimer's …
(AD), and its accumulation has been considered as the molecular driver of Alzheimer's …
Advances in the development of new biomarkers for Alzheimer's disease
TO Klyucherev, P Olszewski, AA Shalimova… - Translational …, 2022 - Springer
Alzheimer's disease (AD) is a complex, heterogeneous, progressive disease and is the most
common type of neurodegenerative dementia. The prevalence of AD is expected to increase …
common type of neurodegenerative dementia. The prevalence of AD is expected to increase …
[HTML][HTML] Lysosome dysfunction as a cause of neurodegenerative diseases: Lessons from frontotemporal dementia and amyotrophic lateral sclerosis
Frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS) are fatal
neurodegenerative disorders that are thought to exist on a clinical and pathological …
neurodegenerative disorders that are thought to exist on a clinical and pathological …
Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS
M DeJesus-Hernandez, IR Mackenzie, BF Boeve… - Neuron, 2011 - cell.com
Several families have been reported with autosomal-dominant frontotemporal dementia
(FTD) and amyotrophic lateral sclerosis (ALS), genetically linked to chromosome 9p21 …
(FTD) and amyotrophic lateral sclerosis (ALS), genetically linked to chromosome 9p21 …
Caspase-1 inhibition alleviates cognitive impairment and neuropathology in an Alzheimer's disease mouse model
J Flores, A Noël, B Foveau, J Lynham, C Lecrux… - Nature …, 2018 - nature.com
Alzheimer's disease (AD) is an intractable progressive neurodegenerative disease
characterized by cognitive decline and dementia. An inflammatory neurodegenerative …
characterized by cognitive decline and dementia. An inflammatory neurodegenerative …
Progranulin, lysosomal regulation and neurodegenerative disease
The discovery that heterozygous and homozygous mutations in the gene encoding
progranulin are causally linked to frontotemporal dementia and lysosomal storage disease …
progranulin are causally linked to frontotemporal dementia and lysosomal storage disease …
Strikingly different clinicopathological phenotypes determined by progranulin-mutation dosage
KR Smith, J Damiano, S Franceschetti… - The American Journal of …, 2012 - cell.com
We performed hypothesis-free linkage analysis and exome sequencing in a family with two
siblings who had neuronal ceroid lipofuscinosis (NCL). Two linkage peaks with maximum …
siblings who had neuronal ceroid lipofuscinosis (NCL). Two linkage peaks with maximum …
The pathobiology of TDP-43 C-terminal fragments in ALS and FTLD
BA Berning, AK Walker - Frontiers in neuroscience, 2019 - frontiersin.org
During neurodegenerative disease, the multifunctional RNA-binding protein TDP-43
undergoes a vast array of post-translational modifications, including phosphorylation …
undergoes a vast array of post-translational modifications, including phosphorylation …
Sortilin-mediated endocytosis determines levels of the frontotemporal dementia protein, progranulin
The most common inherited form of Frontotemporal Lobar Degeneration (FTLD) known
stems from Progranulin (GRN) mutation and exhibits TDP-43 plus ubiquitin aggregates …
stems from Progranulin (GRN) mutation and exhibits TDP-43 plus ubiquitin aggregates …
The lysosomal function of progranulin, a guardian against neurodegeneration
Progranulin (PGRN), encoded by the GRN gene in humans, is a secreted growth factor
implicated in a multitude of processes ranging from regulation of inflammation to wound …
implicated in a multitude of processes ranging from regulation of inflammation to wound …